JP2005507005A - 組織特異的螢光キレート - Google Patents

組織特異的螢光キレート Download PDF

Info

Publication number
JP2005507005A
JP2005507005A JP2003538170A JP2003538170A JP2005507005A JP 2005507005 A JP2005507005 A JP 2005507005A JP 2003538170 A JP2003538170 A JP 2003538170A JP 2003538170 A JP2003538170 A JP 2003538170A JP 2005507005 A JP2005507005 A JP 2005507005A
Authority
JP
Japan
Prior art keywords
tetraazacyclododecane
solution
chelate
europium
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003538170A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005507005A5 (cg-RX-API-DMAC7.html
Inventor
イー. キーファー,ギャリー
ジェイ. ボーンホップ,ダリル
Original Assignee
テキサス テック ユニバーシティー
ダウ グローバル テクノロジーズ インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テキサス テック ユニバーシティー, ダウ グローバル テクノロジーズ インコーポレイティド filed Critical テキサス テック ユニバーシティー
Publication of JP2005507005A publication Critical patent/JP2005507005A/ja
Publication of JP2005507005A5 publication Critical patent/JP2005507005A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003538170A 2001-10-22 2002-10-22 組織特異的螢光キレート Pending JP2005507005A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35568401P 2001-10-22 2001-10-22
PCT/US2002/034242 WO2003035655A1 (en) 2001-10-22 2002-10-22 Tissue specific fluorescent chelates

Publications (2)

Publication Number Publication Date
JP2005507005A true JP2005507005A (ja) 2005-03-10
JP2005507005A5 JP2005507005A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=23398394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003538170A Pending JP2005507005A (ja) 2001-10-22 2002-10-22 組織特異的螢光キレート

Country Status (6)

Country Link
US (1) US6962690B2 (cg-RX-API-DMAC7.html)
EP (1) EP1438318B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005507005A (cg-RX-API-DMAC7.html)
AT (1) ATE309254T1 (cg-RX-API-DMAC7.html)
DE (1) DE60207288T2 (cg-RX-API-DMAC7.html)
WO (1) WO2003035655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049096A2 (en) * 2003-11-14 2005-06-02 Dow Global Technologies Inc. Protein and polymer conjugates as chelants with enhanced blood retention
DE102004022628A1 (de) * 2004-05-07 2005-12-15 Sensient Imaging Technologies Gmbh FRET-Bioassay
US20060210479A1 (en) * 2004-08-10 2006-09-21 Dow Global Technologies Inc. Targeting chelants and chelates
WO2006026038A1 (en) * 2004-08-26 2006-03-09 Mallinckrodt Inc. Luminescent metal complexes for monitoring renal function
EP1885817B1 (en) * 2005-05-11 2016-05-11 University Of Durham Responsive luminescent lanthanide complexes
DK1885817T3 (en) 2005-05-11 2016-08-22 Univ Durham Luminescent lanthanide OF RESPONSE
GB0613823D0 (en) 2006-07-12 2006-08-23 Univ Durham Assay
US7996068B2 (en) * 2007-03-14 2011-08-09 The Board Of Trustees Of The Leland Stanford Junior University Surgical method and apparatus for identification of fluorescence
WO2009039466A1 (en) 2007-09-20 2009-03-26 Vanderbilt University Free solution measurement of molecular interactions by backscattering interferometry
US20100036260A1 (en) 2008-08-07 2010-02-11 Remicalm Llc Oral cancer screening device
WO2011156713A1 (en) 2010-06-11 2011-12-15 Vanderbilt University Multiplexed interferometric detection system and method
US9562853B2 (en) 2011-02-22 2017-02-07 Vanderbilt University Nonaqueous backscattering interferometric methods
US9273949B2 (en) 2012-05-11 2016-03-01 Vanderbilt University Backscattering interferometric methods
WO2016118812A1 (en) 2015-01-23 2016-07-28 Vanderbilt University A robust interferometer and methods of using same
EP3408649B1 (en) 2016-01-29 2023-06-14 Vanderbilt University Free-solution response function interferometry

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
US4976950A (en) 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents
US5312922A (en) 1992-04-06 1994-05-17 Nordion International Inc. Europium and terbium chelators for time-resolved fluorometric assays
US5714604A (en) 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
ATE254129T1 (de) 1996-04-19 2003-11-15 Dow Global Technologies Inc Fluoreszierende chelate als gewebespezifische bildgebende mittel
WO2003020701A2 (en) * 2001-09-04 2003-03-13 Texas Tech University Multi-use multimodal imaging chelates

Also Published As

Publication number Publication date
US20030099598A1 (en) 2003-05-29
WO2003035655A1 (en) 2003-05-01
US6962690B2 (en) 2005-11-08
EP1438318B1 (en) 2005-11-09
ATE309254T1 (de) 2005-11-15
DE60207288D1 (de) 2005-12-15
DE60207288T2 (de) 2006-05-18
EP1438318A1 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
AU2002323528B2 (en) Multi-use multimodal imaging chelates
AU719002B2 (en) Fluorescent chelates as visual tissue specific imaging agents
JP6896733B2 (ja) 二量体造影剤
US6277841B1 (en) Quinoline ligands and metal complexes for diagnosis and therapy
AU2002323528A1 (en) Multi-use multimodal imaging chelates
US6962690B2 (en) Tissue specific fluorescent chelates possessing long wavelength UV excitation
KR102703312B1 (ko) 조영제
US9783554B2 (en) Lanthanide ion complexes and imaging method
CN109963838B (zh) 二聚造影剂
TWI664981B (zh) 用於多模式、非侵入性的腫瘤特定治療診斷前藥之鑭系元素工具箱
AU2002336663A1 (en) Tissue specific fluorescent chelates
CN115634295B (zh) 一种近红外荧光/磁共振双模探针及其制备方法和应用
HK1257515B (en) Dimeric contrast agents
HK1257515A1 (en) Dimeric contrast agents

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051021

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090512